Literature DB >> 25019129

Drug development: Illuminated targets.

Megan Cully.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 25019129     DOI： 10.1038/511s12a

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  8 in total

1.  [Pharmacodynamic properties of N-dipropylacetic acid].

Authors:  H MEUNIER; G CARRAZ; Y NEUNIER; P EYMARD; M AIMARD
Journal:  Therapie       Date:  1963 Mar-Apr       Impact factor: 2.070

2.  Efficacy and tolerability of adjunctive brivaracetam in adults with uncontrolled partial-onset seizures: a phase IIb, randomized, controlled trial.

Authors:  Wim Van Paesschen; Edouard Hirsch; Martin Johnson; Ursula Falter; Philipp von Rosenstiel
Journal:  Epilepsia       Date:  2012-07-19       Impact factor: 5.864

3.  Revisiting AMPA receptors as an antiepileptic drug target.

Authors:  Michael A Rogawski
Journal:  Epilepsy Curr       Date:  2011-03       Impact factor: 7.500

Review 4.  The pharmacologic treatment of Dravet syndrome.

Authors:  Catherine Chiron; Olivier Dulac
Journal:  Epilepsia       Date:  2011-04       Impact factor: 5.864

Review 5.  Brivaracetam for the treatment of epilepsy in adults.

Authors:  Marco Mula
Journal:  Expert Rev Neurother       Date:  2014-04       Impact factor: 4.618

6.  The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam.

Authors:  Berkley A Lynch; Nathalie Lambeng; Karl Nocka; Patricia Kensel-Hammes; Sandra M Bajjalieh; Alain Matagne; Bruno Fuks
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-21       Impact factor: 11.205

Review 7.  Functional biology of the alpha(2)delta subunits of voltage-gated calcium channels.

Authors:  Anthony Davies; Jan Hendrich; Alexandra Tran Van Minh; Jack Wratten; Leon Douglas; Annette C Dolphin
Journal:  Trends Pharmacol Sci       Date:  2007-04-02       Impact factor: 14.819

8.  Drug screening in Scn1a zebrafish mutant identifies clemizole as a potential Dravet syndrome treatment.

Authors:  Scott C Baraban; Matthew T Dinday; Gabriela A Hortopan
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919
  8 in total
  3 in total

1.  Copper-uptake is critical for the down regulation of synapsin and dynamin induced by neocuproine: modulation of synaptic activity in hippocampal neurons.

Authors:  Patricio A Castro; Alejandra Ramirez; Fernando J Sepúlveda; Christian Peters; Humberto Fierro; Javier Waldron; Sandra Luza; Jorge Fuentealba; Francisco J Muñoz; Giancarlo V De Ferrari; Ashley I Bush; Luis G Aguayo; Carlos M Opazo
Journal:  Front Aging Neurosci       Date:  2014-12-03       Impact factor: 5.750

2.  Antiepileptogenic Effect of Subchronic Palmitoylethanolamide Treatment in a Mouse Model of Acute Epilepsy.

Authors:  Julia M Post; Sebastian Loch; Raissa Lerner; Floortje Remmers; Ermelinda Lomazzo; Beat Lutz; Laura Bindila
Journal:  Front Mol Neurosci       Date:  2018-03-14       Impact factor: 5.639

Review 3.  The Endocannabinoid System in Glial Cells and Their Profitable Interactions to Treat Epilepsy: Evidence from Animal Models.

Authors:  Jon Egaña-Huguet; Edgar Soria-Gómez; Pedro Grandes
Journal:  Int J Mol Sci       Date:  2021-12-08       Impact factor: 5.923
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.